In this study, ambient TSP, PM10, and PM2.5 in a residential area located in the northern part of Seoul were monitored every other month for 1 year from April 2005 to February 2006. The monthly average levels of TSP, PM10, and PM2.5 had ranges of 71 approximately 158, 40 approximately 106, and 28 approximately 43 microg/m(3), respectively. TSP and PM10 showed highest concentration in April; this seems to be due to Asian dust from China and/or Mongolia. However, the fine particle of PM2.5 showed a relatively constant level during the monitoring period. Heavy metals in PM 10 and PM2.5, such as Cr, As, Cd, Mn, Zn and Pb, were also analysed during the same period. The monthly average concentrations of heavy metal in PM2.5 were Cr:1.9 approximately 22.7 ng/m(3); As:0.9 approximately 2.5 ng/m(3); Cd: 0.6 approximately 7 ng/m(3); Mn:6.1 approximately 22.6 ng/m(3); Zn: 38.9 approximately 204.8 ng/m(3), and Pb: 21.6 approximately 201.1 ng/m(3). For the health risk assessment of heavy metals in ambient particles, excess cancer risks were calculated using IRIS unit risk. As a result, the excess cancer risks of chromium, cadmium, and arsenic were shown to be more than one per million based on the annual concentration of heavy metals, and chromium showed the highest excess cancer risk in ambient particles in Seoul.
Pit viper venom commonly causes venom-induced consumptive coagulopathy (VICC), which can be complicated by life-threatening hemorrhage. VICC has a complex pathophysiology affecting multiple steps of the coagulation pathway. Early detection of VICC is challenging because conventional blood tests such as prothrombin time (PT) and activated partial thromboplastin time (aPTT) are unreliable for early-stage monitoring of VICC progress. As the effects on the coagulation cascade may differ, even in the same species, the traditional coagulation pathways cannot fully explain the mechanisms involved in VICC or may be too slow to have any clinical utility. Antivenom should be promptly administered to neutralize the lethal toxins, although its efficacy remains controversial. Transfusion, including fresh frozen plasma, cryoprecipitate, and specific clotting factors, has also been performed in patients with bleeding. The effectiveness of viscoelastic monitoring in the treatment of VICC remains poorly understood. The development of VICC can be clarified using thromboelastography (TEG), which shows the procoagulant and anticoagulant effects of snake venom. Therefore, we believe that TEG may be able to be used to guide hemostatic resuscitation in victims of VICC. Here, we aim to discuss the advantages of TEG by comparing it with traditional coagulation tests and propose potential treatment options for VICC.
Circulation Journal Official Journal of the Japanese Circulation Society http://www. j-circ.or.jp diomyopathy (CMP) is not an established concept yet, and reports on its epidemiology and clinical characteristics are scarce. Therefore, clinical characteristics of CO-induced CMP and its significance need to be elucidated.Stress-induced CMP, also known as takotsubo CMP, is a type of heart failure characterized by rapid reversibility and distinctive contraction patterns in the left ventricle. 13-16 It can be triggered by emotional events, and is found predominantly in postmenopausal women. 13,15 Takotsubo CMP occurs under the condition of catecholamine excess, as in exogenous epinephrine, pheochromocytoma, and acute neurologic disorders (eg, intracranial bleeding and cerebral infarction). 17-21There are a number of common factors between CO-induced CMP and takotsubo CMP, although the clinical features are not completely identical. Here, we investigate CO-induced CMP in terms of its epidemiology, clinical characteristics, and prognosis.arbon monoxide (CO) is an odorless, colorless, and nonirritating gas. 1,2 Even a small amount of CO exposure is possibly associated with organ damage and specific toxic effects. Acute CO poisoning is a major cause of mortality and morbidity worldwide. 1,2 According to previous reports, the main mechanism of CO toxicity is ischemic hypoxia secondary to hypoxemia. 1,3,4 Specifically, the heart is the major target organ of acute CO poisoning. 3 Cardiovascular manifestations demonstrated in previous reports include arrhythmia, pulmonary edema, heart failure, and myocardial infarction. 5-10 Cardiac failure was presented in patients who experienced acute CO poisoning. Background: Previous reports demonstrated mechanisms of cardiac toxicity in acute carbon monoxide (CO) poisoning. Still, none established CO-induced cardiomyopathy (CMP) as a clinical entity. The aim of this study is to investigate CO-induced CMP in patients with acute CO poisoning in terms of its epidemiology, clinical characteristics, and prognosis.
Electronic cigarettes (ECs) are a device that aerosolize liquid nicotine by heating a solution of nicotine, glycerol and flavoring agents. The awareness and the usage of ECs has increased in many countries. Due to the online sales and the absence of EC regulations, the prevalence of EC usage is especially high in adolescents and young adults. Due to the large amount and the high nicotine concentration of EC liquid, the ingestion for suicide can lead to cardiac death. We had two patients, a 27-year-old male who ingested about 23 mg/kg of nicotine and a 17-year-old female who ingested about 30 mg/kg of nicotine. Both patients presented seizure-like movement and cardiac arrest. They had metabolic acidosis and transient cardiomyopathy. They were ultimately discharged with a cerebral performance category of 2 and 4, respectively. Increasing EC use may produce more cases of medical problems or suicide by nicotine intoxication.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.